Clinical Trial Update: A Study To Evaluate The Effect Of GW876008 On The Pharmacokinetics Of Oral Contraceptive Pills [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study to evaluate whether GW876008 affects the pharmacokinetics of oral contraceptive pills; the trial in individuals with social phobia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• GW876008
• Oral contraceptive pills (combined oral contraceptive)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Social Phobia | Phase 1 | Status: TERMINATED